Shares of Accenture plc (NYSE:ACN) have moved 4.12% so far this year and they are now 2.38% from where they were around this time last year.
Over the last six months the stock has moved 1.90%, while it has moved -0.43% over the last quarter. Over the last week and the last one month, the stock has moved 1.25% and 2.75%, respectively.
The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction. Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.
Recently, Accenture (NYSE:ACN) has hired Rafael Lopez as a managing director in its Health & Public Service practice in North America. Lopez joins Accenture from the U.S. Department of Health and Human Services (HHS), where he served as the commissioner of the Administration on Children, Youth and Families.
Studying the stock’s moving averages shows its 20-Day Simple Moving Average to be $0.68% while 50-Day Simple Moving Average is $1.37% and 200-Day Simple Moving Average is $3.27%.
The stock has declined to a low of $6.21% over the last 50 days and jumped to a high of $-3.62% over the same period. However, the stock’s price range over the last 12 months is a high of $-3.62% and a low of $12.23%.
Analysts tracking Accenture plc have an average recommendation of 2.30 on its stock. For clarity, recommendation of 1 implies STRONG BUY, 3 implies HOLD and 5 implies SELL.
The stock is currently trading at $121.95, but it should be trading at $130.68 by the end of the next 12 months according to analysts. The current stock price implies the company has a dividend yield of 1.98%.
The stock’?s average volume, which is the average of three months, is 2.33M, while its relative volume is 0.87.
Insiders own 0.20% of Accenture plc, while institutional investors own 81.40% of the company.
Of the company’s 644.02M shares outstanding, 583.32M are free float. Of the floating shares, 1.30% have been sold short and that brings short ratio to 3.26.
Accenture plc reported EPS for the last fiscal year and the current year?s EPS is expected to increase 35.40% over the previous year’s EPS.
The company’s next earnings date is scheduled for Jun 22/b.